Professional Documents
Culture Documents
Wound and Bleeding Control
Wound and Bleeding Control
CONTROL
WOUNDS:
• Wound is caused when any tissue
(Skin, Muscle, Bone, etc. ) is torn or cut
by an injury.
• DEPTH of the wound is more
important than AREA.
TYPES OF WOUND:
• OPEN WOUND
• CLOSED WOUND
OPEN WOUND:
• INCISED WOUND
• LACERATED WOUND
• PUNCTURED WOUND
• GRAZE OR ABRASION
• GUN SHOT WOUND
• AVULSION AMPUTATION
CLOSED WOUND:
• CONTUSED WOUND
Introduction
• Review types of injuries
• Review Tactical Combat Casualty
Care
• Evaluate and control bleeding
• Take home message:
HEMORRHAGE CONTROL
SAVES LIVES
Core Skills Control Bleeding 4
Sources of Bleeding
• Arterial
- Rapid, profuse and pulsating
- Bright red in color
• Venous
- Steady flow, nonpulsating
- Dark red or maroon in color
• Capillary
- Slow and oozing
- Often clots spontaneously, not dangerous
TYPES OF BLEEDING:
• EXTERNAL BLEEDING
• INTERNAL BLEEDING
VARIETIES OF BLEEDING:
ARTERIAL BLEEDING:
• BLOOD COMES FROM AN ARTERY.
• BLOOD IS BRIGHT RED IN COLOUR.
• BLOOD COMES IN JETS & IT CORRESPONDS TO
HEART BEAT.
• BLOOD LOSS IS RAPID & PROFUSE & CAN CAUSE
DEATH QUICKLY.
TYPES OF WOUNDS
CONTUSED
INCISED
PUNCTURED
BURNS
LACERATED
External Bleeding
• Lacerations
• Abrasions
• Puncture wounds
• Amputations
• Avulsions
Core Skills Control Bleeding 9
Laceration
• To control severe
bleeding of thigh
and lower leg
• Located at front,
center part of
crease in the groin
WINDLASS
Place tourniquet
above the injury
site
C-A-T Step 3
CMAST 39
Tourniquet Application
• Place tourniquet between the heart
and wound
• Wrap tourniquet around extremity
• Tighten UNTIL BLEEDING
STOPS
Prof. M.C.Bansal
MBBS., MS., FICOG., MICOG.
Founder Principal & Controller,
Jhalawar Medical College & Hospital Jjalawar.
MGMC & Hospital , sitapura ., Jaipur.
History of Transfusions
• Blood transfused in humans since mid-
1600’s
• 1828 – First successful transfusion
• 1900 – Landsteiner described ABO
groups
• 1916 – First use of blood storage
• 1939 – Levine described the Rh factor
First human blood transfusion
Philip (1825)
Discovery of ABO type
Landsteiner
(1900))
Blood Transfusion
Successful blood transfusion is relatively recent
• Crossmatching
• Anticoagulation
WHAT IS ANTIBODYS ?
Antibodies is a protein substance
develop in the body in response to the
presence of an antigen that has entered
the body
PURPOSE OFBLOOD
TRANSFUSION
THERAPY
* REPLACEMENT
* THERAPEUTIC
1.To restore intravascular volume with
whole blood or albumin.
2. To restore the oxygen capacity of
blood by replacing red blood cells.
3. To replace clotting factor and
correction of anemia
Blood Transfusion
Type of Transfusion :
■ Whole Blood ;
■ Blood Component ;
■ Plasma Substitutes ;
Use of whole blood is considered to be a waste of
resources
DEFINITIONS
BLOOD PRODUCT = Any therapeutic substance prepared from
human blood
WHOLE BLOOD = Unseparated blood collected into an
approved container containing an anticoagulant preservative
solution
Platelet-
RBC’s rich
Plasma
Differential Centrifugation
Second Centrifugation
RBC’s Platelet-rich
Plasma
Second
Platelet Plasma
RBC’s Concentrat
e
Whole Blood
• Storage
– 4° for up to 35 days
• Indications
– Massive Blood Loss/Trauma/Exchange Transfusion
• Considerations
– Use filter as platelets and coagulation factors will not
be active after 3-5 days
– Donor and recipient must be ABO identical
Blood Components
THE PRBC
Storage
-2–6OC
Unit of issue
- 1 donation ( unit or pack )
Administration
- ABO & Rh compatible
- Never add medication to a unit
- Complete transfusion within 4 hrs of
commencement
M 1
e
m
Indications
- Acute blood loss with > 20% loss of
blood volume
Trauma
Surgery - Trigger – 10gm% - 8gm%
Rate of development of anemia,
General condition and type of
surgery
Radiotherapy
Platelets
• The platelets are separated from the plasma by
centrifugation.
• Thrombocytopenia
(< 50,000)
• Platelet dysfunction
Dextran
• Most widely used
• Low/Middle M.W. (40,000-70,000)
• Massive transfusion could impair coagulation
• Occasional ALLERGIC reaction
Hydroxyethyl Starch Formulation (HES)
• More stable
• Containing essential electrolytes
• No allergic reaction
--Volume Expander
Cryoprecipitate
• Description
– Precipitate formed/collected when FFP is thawed at 4°
• Storage
– After collection, refrozen and stored up to 1 year at -18°
• Indication
– Fibrinogen deficiency or dysfibrinogenemia
– vonWillebrands Disease
– Factor VIII or XIII deficiency
– DIC (not used alone)(Disseminated intravascular
coagulation)
• Considerations
– ABO compatible preferred (but not limiting)
– Usual dose is 1 unit/5-10 kg of recipient body weight
• Although blood transfusions can be
life-saving, they are not without risks.
The most serious risks are
transfusion reactions and infections.
Transfusion Complications
• Acute Transfusion Reactions (ATR’s)
• Chronic Transfusion Reactions
• Transfusion related infections
Acute Transfusion Reactions
• Hemolytic Reactions (AHTR)
• Febrile Reactions (FNHTR)
• Allergic Reactions
• TRALI(Transfusion related acute lung
injury)
• Coagulopathy with Massive transfusions
• Bacteremia
Can be fatal
Symptoms of AHTR
• High fever/chills
• Hypotension
• Back/abdominal pain
• Oliguria
• Dyspnea
• Dark urine
• Pallor
What to do?
If an AHTR occurs
• STOP TRANSFUSION
• ABC’s
• Maintain IV access and run IVF (NS or LR)
• Monitor and maintain BP/pulse
• Give diuretic
• Obtain blood and urine for transfusion reaction
workup
• Send remaining blood back to Blood Bank
Febrile Nonhemolytic Transfusion
Reactions (FNHTR)
• Definition--Rise in patient temperature >1°C (associated
with transfusion without other fever precipitating
factors)
• Occurs with approx 1% of PRBC transfusions and
approx 20% of Plt transfusions
• FNHTR caused by alloantibodies directed against HLA
antigens
• Need to evaluate for AHTR and infection
Allergic Nonhemolytic Transfusion
Reactions
• Etiology
– May be due to plasma proteins or blood
preservative/anticoagulant
– Best characterized with IgA given to an IgA deficient
patients with anti-IgA antibodies
• Presents with urticaria and wheezing
• Treatment
– Mild reactions—Can be continued after Benadryl
– Severe reactions—Must STOP transfusion and may require
steroids or epinephrine
• Prevention—Premedication (Antihistamines)
TRALI
Transfusion Related Acute Lung Injury
• Clinical syndrome similar to ARDS
• Occurs 1-6 hours after receiving plasma-
containing blood products
• Caused by WBC antibodies present in
donor blood that result in pulmonary
leukostasis
• Treatment is supportive
• High mortality
Transfusion Associated
Infections
• Hepatitis C
• Hepatitis B
• HIV
• CMV
– CMV can be diminished by leukoreduction,
which is indicated for immunocompromised
patients
ThAnk You!
Hope you learned
something!